Combined analysis of cytokine genotype polymorphism and the level of expression with allograft function in African-American renal transplant patients

Transplant Immunology

Volumn 11, Issue 1, 2003, Pages 107-119

  McDaniel, D O ^a   Barber, W H ^a   Nguyan, C ^a   Rhodes, S W ^a   May, W L ^a   McDaniel, L S ^a   Vig, P J S ^a   Jemeson, L L ^a   Butkus, D E ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

African American; Cytokine genotype; HLA class II; Polymorphisms; Rejection episodes; Transplantation

Indexed keywords

BETA ACTIN; CYTOKINE; DNA; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; MARKER; MESSENGER RNA; PRIMER RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MARKER; DNA POLYMORPHISM; FEMALE; FUNCTIONAL ASSESSMENT; GENETIC ANALYSIS; GENETIC CODE; GENETIC VARIABILITY; GENOTYPE; HLA MATCHING; HUMAN; IMMUNE RESPONSE; KIDNEY ALLOGRAFT REJECTION; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEGRO; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROTECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

AFRICAN AMERICANS; CYTOKINES; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; POLYMORPHISM, GENETIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 0037691735     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(02)00171-5     Document Type: Article

References (62)

1. Stepkowski SM. Immunobiology of allgraft rejection. In: Kahan BD, Ponticielli C, editors. Principles and Practice of Renal Transplantation. Malden, MA, USA: Blackwell Science Inc, 2000. p. 41-87.
2. Fuggle SV, Koo DD. Cell adhesion molecules in clinical renal transplantation. Transplantation 1998;65:763-769.
3. Halloran PF, Broski AP, Batiuk TD, Madrenas J. The molecular immunology of acute rejection: An overview. Transplant Immunol 1993;1:3-27.
4. Suthanthiran M. Acute rejection of renal allografts: Mechanistic insights and therapeutic options. Kidney Int 1997;51:1289-1304.
5. Mottram PL, Han W-R, Purcell LJ, McKenzie IFC, Hancock WW. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and Interferon-γ in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation 1995;59:559-565.
6. Minguela A, Torío A, Marín L, et al. Implication of Th1, Th2, and Th3 cytokines in liver graft acceptance. Transplant Proc 1999;31:519-520.
7. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor a (TNF-α) promotor in transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-3199.
8. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the IL-10 gene. Eur J Immunogenet 1997;24:1-8.
9. Kroeger KM, Carville KS, Abraham LJ. The -308 tumour necrosis factor-α promoter polymorphism affects transcription. Mol Immunol 1997;34:391-399.
10. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ. Hutchinson IV. In vitro production correlates with CA repeat polymorphism in the human IFN-γ gene. Eur J Immunogenet 1999;26:1-3.
11. Bouma G, Crusius JBA, Oudkerk-Pool M, et al. Secretion of tumour necrosis factor-α and lymphotoxin-α in relation to polymorphisms in the TNF genes and HLA-DR alleles: Relevance for inflammatory bowel disease. Scand J Immunol 1996;43:456-463.
12. Perrey C, Pravica V, Sinnott PJ, Hutchinson IV. Genotyping for polymorphisms in interferon-γ, interleukin-10, transforming growth factor-β1 and tumour necrosis factor-a genes: A technical report. Transplant Immunol 1998;6:193-197.
13. Reynard MP, Turner D, Navarrete CV. Allele frequencies of polymorphisms of the tumour necrosis factor-α, interleukin-10, interferon-γ and interleukin-2 genes in north European Caucasoid group from the UK. Eur J Immunogenet 2000;27(4):241-249.
14. Rood MJ, Van Krugten MV, Zanelli E, et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2000;43:129-134.
15. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-1376.
16. Jahromi M, Millward A, Demaine A. A CA repeat polymorphism of the IFN-γ gene is associated with susceptibility to type 1 diabetes. J Interferon Cytokine Res 2000;20(2):187-190.
17. Bathgate AJ, Pravica V, Perry C, et al. The effect of polymorphisms in tumor necrosis factor-α, interleukin-10, and transforming growth factor-β1 genes in acute hepatic allograft rejection. Transplantation 2000;69:1514-1517.
18. Sankaran D, Asderakis A, Ashraf S, et al. Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 1999;56:281-288.
19. Hutchinson IV, Pravica V, Sinnott P. Genetic regulation of cytokine synthesis: Consequences for acute and chronic organ allograft rejection. Graft 2000;56:281.
20. Suthanthiran M. The importance of genetic polymorphisms in renal transplantation. Curr Opin Urol 2000;10(2):71-75.
21. Asderakis A, Sankaran D, Dyer P, et al. Association of polymorphisms in the human interferon-γ and interleukin-10 gene with acute and chronic kidney transplant outcome. The cytokine effect on transplantation. Transplantation 2001;71:674-678.
22. Hutchinson IV, Turner D, Sankaran D, Awad M, Pravica V, Sinnott P. Cytokine genotypes in allograft rejection: Guidelines for immunosuppression. Transplant Proc 1998;30:3991-3992.
23. Wilson AG, Di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human Tumour Necrosis Factor-α (TNF-α) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1992;1(5):353.
24. John S, Turner D, Donn R, et al. Two novel biallelic polymorphisms in the IL-2 gene. Eur J Immunogenet 1998;25:419-420.
25. Abdallah AN, Cucchi-Mouillot P, Biteau N, Cassaigne A, Haras D, Iron A. Analysis of the polymorphism of the tumour necrosis factor (TNF) gene and promoter and of circulating TNF-α levels in heart-transplant patients suffering or not suffering from sever rejection. Eur J Immunogenet 1999;26:249-255.
26. Sankaran D, Turner DM, Johnson RW, et al. Interleukin-10 and tumour necrosis factor-α gene polymorphisms predict renal transplant outcome. Eur J Immunogenet 1997;24:65-69.
27. Pravica V, Perrcy C, Plevris J, et al. Elevated frequency of TNF-a - 308A allele in patients requiring liver transplantation. Immunology 1997;92:13.3.
28. Pelletier R, Pravica V, Perrey C, et al. Evidence for a genetic predisposition towards acute rejection after kidney and simultaneous kidney-pancreas transplantation. Transplantation 2000;70:674-680.
29. Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchinson IV. Genotypic variation in the transforming growth factor-β1 gene. Association with transforming growth factor-β1 production, fibrotic lung disease and graft fibrosis after lung transplantation. Transplantation 1998;66:1014-1020.
30. Densem CG, Hutchinson IV, Cooper A, Yonan N, Brooks NH. Polymorphism of the transforming growth factor-β1 gene correlates with the development of coronary vasculopathy following cardiac transplantation. J Heart Lung Transplant 2000;19:551-556.
31. Suthanthiran M, Li B, Song JO, et al. Transforming growth factor-β1 hyperexpression in African-American hypertension and/or target organ damage. PNAS 2000;97:3479-84.
32. Fernández-Real JM, Broch M, Vendrell J, et al. Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes 2000;49:517-520.
33. Cox ED, Hoffmann SC, DiMercurio BS, et al. Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation 2001;72:720-726.
34. Pravica V, Perrey C, Stevens A, Lee J-H, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-γ gene: Absolute correlation with a polymorphic CA microsatellite marker of high IFN-γ production. Hum Immunol 2000;61:863-866.
35. Turner DM, Grant SC, Yonan N, et al. Cytokines genotypes and heart transplant rejection. Transplantation 1997;64:776-779.
36. Blin N, Stafford DW. A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 1976:3:2303-2308.
37. Lagoo-Deenadayalan S, Lagoo AS, Barber WH, Hardy KJ. A standardized approach to PCR-based semiquantitation of multiple cytokine gene transcripts from small cell samples. Lymphokine Cytokine Res 1993;12:59-67.
38. Merville P, Pouteli-Noble C, Wijdenes J, Potaux L, Touraine JL, Banchereau J. Detection of single cells secreting IFN-gamma, IL-6 and IL-10 in irreversibly rejected human kidney allografts, and their modulation by IL-2 and IL-4. Transplantation 1993;55:639-646.
39. Obayashi H, Nakamura N, Fukui M, et al. Influence of TNF microsatellite polymorphisms (TNF-α) on age-at-onset of insulin-dependent diabetes mellitus. Hum Immunol 1999;60:974-978.
40. Shoskes DA, Parfrey NA, Halloran PF. Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation 4990;49(1):201-207.
41. Shoskes DA, Halloran PF. Ischemic injury induces altered MHC gene expression in kidney by an IFN-γ dependent pathway. Transplant Proc 1991;23(1):599-601.
42. Tullius SG, Hancock WW, Heemann U, Azuma H, Tilney NL. Reversibility of chronic renal allograft rejection. Critical effect of time after transplantation suggests both host immune dependent and independent phases of progressive injury. Transplantation 1994;58(1):93-99.
43. Scantlebury V, Gjerston D, Eliasziw M. Effect of HLA mismatch in African-Americans. Transplantation 1998;65:586-588.
44. Cosio FG, Qiu W, Henry ML, Falkenhain ME, Elkhammas EA, Davies EA. Factors related to the donor organ are major determinants of renal allograft function and survival. Transplantation 1996;62:1571-1576.
45. Mahoney RJ, Szatkowski MA, White BA, Leeber DA. Tumor necrosis factor beta gene polymorphism and early primary kidney allograft loss. Hum Immunol 1996;50:148-150.
46. Cox DE, Hoffmann SC, DiMercurio BS, et al. Cytokine polymorphic analyses indicate ethnic differences in the allelic distribution of interleukin-2 and interleukin-6. Transplantation 2001;72(4):720-726.
47. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994;76:241-251.
48. Weimer R, Zipperle S, Daniel V, Carl S, Staehler G, Opelz G. Pretransplant CD4+ helper function and IL-10 response predict risk of acute kidney graft rejection. Transplantation 1996;62:1606-1614.
49. Xu GP, Sharma VK, Li B, et al. Intragraft expression of IL-10 messenger RNA: A novel correlate of renal allograft rejection. Kidney Int 1995;48:1504-1507.
50. De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-1220.
51. Eckels DD, Geiger MJ, Sell TW, Gorski JA. Involvement of class II-β chain amino acid residues 85 and 86 in T cell allorecognition. Hum Immunol 1990;27:240-253.
52. Hurley CK, Ziff BL, Silver J, Gregersen PK, Hartzman R, Johnson AH. Polymorphism of the HLA-DR1 haplotype in American-Blacks: Identification of a DR1 β-chain determinant recognized in the mixed lymphocyte reaction. J Immunol 1988;140:4019-4025.
53. McDaniel DO, Rhodes SW, Barber WH, McDaniel LS, Butkus DE. Influence of polymorphism in TGF-β1, IL-10 and IFN-γ gene in delayed graft function and REs in African-Americans. Hum Immunol 2001;62(suppl 1):27.
54. Virelizier JL, Perez N, Arenzana-Seisdedos F, Devos R. Pure interferon gamma enhances class II HLA antigens on human monocyte cell lines. Eur J Immunol 1984;14(1):106-108.
55. Halloran PF, Wadgymar A, Autenried P. The regulation of expression of major histocompatibility complex products. Transplantation 1986;41:413-420.
56. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon-gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J Exp Med 1993;178:1041-1048.
57. De Waal Malefyt R, Haanen J, Spits H, et al. Interleukin-10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J Exp Med 1991;174:915-924.
58. McDaniel DO, Jemison L, Pande M, Butkus DE, Barber WH. HLA-DPβ antigen regulation during early kidney transplantation. Hum Immunol 1999;60(Suppl):97.
59. Jackson A, Palmer S, Davis RD, et al. Cytokine genotypes in kidney, heart, and lung recipients: Consequences for acute and chronic rejection. Transplant Proc 2001;33:489-490.
60. Ahuja SS, Shrivastav S, Danielpour D, Balow JE, Boumpas DT. Regulation of transforming growth factor-β1 and its receptor by cyclosporine in human T lymphocytes. Transplantation 1995;60(7):718-723.
61. Hojo M, Morimoto T, Maluccio M, et al. Cyclosporine induces cancer progression by cell-autonomous mechanism. Nature 1999;397(6719):471-472.
62. Shin G-T, Khanna A, Ding R, et al. In-vivo expression of transforming growth factor-β1 in humans: Stimulation by cyclosporine. Transplantation 1998;65:313-318.